A novel function for programmed death ligand-1 regulation of angiogenesis

American Journal of Pathology

Volumn 178, Issue 4, 2011, Pages 1922-1929

  Jin, Yiping ^a   Chauhan, Sunil K ^a   Annan, Jaafar E I ^a   Sage, Peter T ^b   Sharpe, Arlene H ^b   Dana, Reza ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; PROGRAMMED DEATH 1 LIGAND; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA EPITHELIUM; GENETIC TRANSFECTION; IN VITRO STUDY; INNATE IMMUNITY; LUNG BLOOD VESSEL; MACROPHAGE; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

EID: 79953647522     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.12.027     Document Type: Article

References (30)

1. Cursiefen C, Chen L, Saint-Geniez M, Hamrah P, Jin Y, Rashid S, Pytowski B, Persaud K, Wu Y, Streilein JW, Dana R: Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci U S A 2006, 103:11405-11410 (Pubitemid 44156530)
2. Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T, Albuquerque RJ, Richter E, Sakurai E, Newcomb MT, Kleinman ME, Caldwell RB, Lin Q, Ogura Y, Orecchia A, Samuelson DA, Agnew DW, St Leger J, Green WR, Mahasreshti PJ, Curiel DT, Kwan D, Marsh H, Ikeda S, Leiper LJ, Collinson JM, Bogdanovich S, Khurana TS, Shibuya M, Baldwin ME, Ferrara N, Gerber HP, De Falco S, Witta J, Baffi JZ, Raisler BJ, Ambati J: Corneal avascularity is due to soluble VEGF receptor-1. Nature 2006, 443:993-997 (Pubitemid 44646176)
3. Streilein JW, Yamada J, Dana MR, Ksander BR: Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts. Transplant Proc 1999, 31:1472-1475 (Pubitemid 29234906)
4. Niederkorn JY: The immune privilege of corneal allografts. Transplantation 1999, 67:1503-1508
5. Cursiefen C, Masli S, Ng TF, Dana MR, Bornstein P, Lawler J, Streilein JW: Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. Invest Ophthalmol Vis Sci 2004, 45:1117-1124 (Pubitemid 38869016)
6. Hayashi T, Yamagami S, Tanaka K, Yokoo S, Usui T, Amano S, Mizuki N: Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site. Invest Ophthalmol Vis Sci 2009, 50:3151-3158
7. Hori J, Wang M, Miyashita M, Tanemoto K, Takahashi H, Takemori T, Okumura K, Yagita H, Azuma M: B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol 2006, 177:5928-5935 (Pubitemid 44628806)
8. Shen L, Jin Y, Freeman GJ, Sharpe AH, Dana MR: The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival. J Immunol 2007, 179:3672-3679
9. Keir ME, Butte MJ, Freeman GJ, Sharpe AH: PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008, 26:677-704
10. Greenwald RJ, Freeman GJ, Sharpe AH: The B7 family revisited. Annu Rev Immunol 2005, 23:515-548
11. Dong H, Zhu G, Tamada K, Chen L: B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999, 5:1365-1369
12. Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K, Azuma M, Yagita H: Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 2002, 169:5538-5545 (Pubitemid 35291652)
13. Loke P, Allison JP: PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc Natl Acad Sci U S A 2003, 100:5336-5341 (Pubitemid 36542706)
14. Nakazawa A, Dotan I, Brimnes J, Allez M, Shao L, Tsushima F, Azuma M, Mayer L: The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells. Gastroenterology 2004, 126:1347-1357 (Pubitemid 38552799)
15. Stuart PM, Pan F, Plambeck S, Ferguson TA: FasL-Fas interactions regulate neovascularization in the cornea. Invest Ophthalmol Vis Sci 2003, 44:93-98 (Pubitemid 36134260)
16. Reed MJ, Iruela-Arispe L, O'Brien ER, Truong T, LaBell T, Bornstein P, Sage EH: Expression of thrombospondins by endothelial cells. Injury is correlated with TSP-1. Am J Pathol 1995, 147:1068-1080
17. Eppihimer MJ, Gunn J, Freeman GJ, Greenfield EA, Chernova T, Erickson J, Leonard JP: Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation 2002, 9:133-145 (Pubitemid 135684689)
18. Mazanet MM, Hughes CC: B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J Immunol 2002, 169:3581-3588
19. Latchman YE, Liang SC, Wu Y, Chernova T, Sobel RA, Klemm M, Kuchroo VK, Freeman GJ, Sharpe AH: PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc Natl Acad Sci U S A 2004, 101:10691-10696 (Pubitemid 38955804)
20. Dana MR, Zhu SN, Yamada J: Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea 1998, 17:403-409 (Pubitemid 28307507)
21. Jin Y, Shen L, Chong EM, Hamrah P, Zhang Q, Chen L, Dana MR: The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking. Mol Vis 2007, 13:626-634 (Pubitemid 46710813)
22. Rodig N, Ryan T, Allen JA, Pang H, Grabie N, Chernova T, Greenfield EA, Liang SC, Sharpe AH, Lichtman AH, Freeman GJ: Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol 2003, 33:3117-3126 (Pubitemid 37428344)
23. Takahashi T, Yamaguchi S, Chida K, Shibuya M: A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J 2001, 20:2768-2778 (Pubitemid 32938560)
24. Dowling D, Hamilton CM, O'Neill SM: A comparative analysis of cytokine responses, cell surface marker expression and MAPKs in DCs matured with LPS compared with a panel of TLR ligands. Cytokine 2008, 41:254-262
25. Oettgen P: Regulation of vascular inflammation and remodeling by ETS factors. Circ Res 2006, 99:1159-1166
26. Svensson S, Jirstrom K, Ryden L, Roos G, Emdin S, Ostrowski MC, Landberg G: ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis. Oncogene 2005, 24:4370-4379 (Pubitemid 40961760)
27. Hori J, Streilein JW: Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 2001, 42:720-726 (Pubitemid 32206914)
28. Hamrah P, Huq SO, Liu Y, Zhang Q, Dana MR: Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J Leukoc Biol 2003, 74:172-178 (Pubitemid 38040413)
29. Her M, Kim D, Oh M, Jeong H, Choi I: Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus. Lupus 2009, 18:501-507
30. Dana MR, Streilein JW: Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci 1996, 37:2485-2494 (Pubitemid 26391286)